HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rodolfo Montironi Selected Research

Castration

4/2023Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis.
2/2022PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?
2/2022Current androgen receptor antagonists under investigation for resistant prostate cancer.
1/2022Trpm8 Expression in Human and Mouse Castration Resistant Prostate Adenocarcinoma Paves the Way for the Preclinical Development of TRPM8-Based Targeted Therapies.
12/2021An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT.
5/2021Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic.
3/2021Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States.
2/2021Treating Prostate Cancer by Antibody-Drug Conjugates.
2/2021Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art.
11/2020Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rodolfo Montironi Research Topics

Disease

214Neoplasms (Cancer)
10/2023 - 01/2002
130Prostatic Neoplasms (Prostate Cancer)
12/2023 - 03/2003
82Carcinoma (Carcinomatosis)
04/2023 - 01/2004
63Renal Cell Carcinoma (Grawitz Tumor)
12/2023 - 01/2009
46Urinary Bladder Neoplasms (Bladder Cancer)
10/2023 - 06/2003
33Adenocarcinoma
01/2022 - 01/2004
26Neoplasm Metastasis (Metastasis)
10/2023 - 03/2002
23Prostatic Intraepithelial Neoplasia
01/2021 - 06/2002
15Margins of Excision
02/2023 - 01/2004
13Carcinogenesis
01/2021 - 04/2006
10Circulating Neoplastic Cells
11/2021 - 01/2017
9Kidney Neoplasms (Kidney Cancer)
01/2020 - 01/2009
8Disease Progression
08/2019 - 10/2008
6Non-Muscle Invasive Bladder Neoplasms
04/2023 - 01/2017
5Testicular Neoplasms (Testicular Cancer)
12/2023 - 09/2015
5Hyperplasia
01/2023 - 04/2005
5Carcinoma in Situ
03/2021 - 12/2005
5Inverted Papilloma
07/2016 - 12/2006
5Atrophy
10/2010 - 10/2007
4Obesity
10/2023 - 05/2010
4Noninfiltrating Intraductal Carcinoma (DCIS)
03/2021 - 03/2013
4Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2021 - 06/2002
4Inflammation (Inflammations)
10/2020 - 07/2011
4Small Cell Carcinoma
12/2018 - 02/2007
4Urogenital Neoplasms
09/2016 - 01/2015
4Lymphatic Metastasis
04/2011 - 03/2002
3Melanoma (Melanoma, Malignant)
01/2022 - 02/2013
3Breast Neoplasms (Breast Cancer)
02/2021 - 04/2006
3Cystitis
07/2016 - 11/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2015 - 11/2012
3Metaplasia
09/2012 - 11/2006

Drug/Important Bio-Agent (IBA)

61Biomarkers (Surrogate Marker)IBA
12/2023 - 09/2003
32Proteins (Proteins, Gene)FDA Link
12/2020 - 03/2002
22Immune Checkpoint InhibitorsIBA
02/2022 - 04/2016
19Hormones (Hormone)IBA
01/2022 - 04/2003
18AndrogensIBA
01/2022 - 01/2004
16Androgen Receptors (Androgen Receptor)IBA
02/2022 - 06/2002
15DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2005
15Prostate-Specific Antigen (Semenogelase)IBA
11/2019 - 06/2002
13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2021 - 11/2013
12AntigensIBA
02/2021 - 11/2006
11Tyrosine Kinase InhibitorsIBA
10/2023 - 04/2011
8Phenobarbital (Luminal)FDA Link
04/2023 - 06/2002
8ParaffinIBA
11/2019 - 04/2005
8ChromatinIBA
10/2015 - 09/2003
7ErbB Receptors (EGF Receptor)IBA
01/2014 - 02/2007
6AntibodiesIBA
02/2021 - 12/2007
6Cell-Free Nucleic AcidsIBA
01/2020 - 01/2018
6PlatinumIBA
01/2019 - 01/2005
6Sunitinib (Sutent)FDA Link
01/2019 - 11/2013
6Succinate Dehydrogenase (Fumarate Reductase)IBA
09/2016 - 10/2013
6Somatostatin Receptors (Somatostatin Receptor)IBA
01/2013 - 01/2008
5Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
01/2023 - 02/2008
5Telomerase (Telomerase Reverse Transcriptase)IBA
01/2023 - 01/2004
5Cisplatin (Platino)FDA LinkGeneric
01/2023 - 01/2008
5Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2022 - 01/2020
5Circulating Tumor DNAIBA
05/2021 - 01/2019
5Formaldehyde (Formol)FDA Link
11/2019 - 04/2005
5Keratin-20 (Cytokeratin 20)IBA
01/2017 - 11/2006
4NivolumabIBA
10/2023 - 01/2016
4enzalutamideIBA
04/2023 - 03/2015
4VimentinIBA
01/2022 - 10/2013
4cabozantinibIBA
01/2021 - 10/2018
4Indicators and Reagents (Reagents)IBA
07/2020 - 04/2006
4Docetaxel (Taxotere)FDA Link
03/2020 - 09/2009
4MicroRNAs (MicroRNA)IBA
01/2020 - 10/2017
4pazopanibFDA Link
10/2018 - 12/2014
4Racemases and Epimerases (Epimerases and Racemases)IBA
07/2016 - 10/2007
4EnzymesIBA
04/2016 - 04/2007
4Anaplastic Lymphoma KinaseIBA
05/2014 - 07/2013
4alpha-methylacyl-CoA racemaseIBA
04/2014 - 02/2007
4bicalutamide (Casodex)FDA LinkGeneric
04/2009 - 01/2004
3LigandsIBA
02/2022 - 12/2018
3Tumor Biomarkers (Tumor Markers)IBA
03/2021 - 01/2005
3Chimeric Antigen ReceptorsIBA
01/2021 - 01/2020
3B7-H1 AntigenIBA
01/2021 - 03/2018
3CytokinesIBA
10/2020 - 08/2016
3Death Domain ReceptorsIBA
01/2020 - 03/2018
3Monoclonal AntibodiesIBA
01/2020 - 03/2012
3RNA (Ribonucleic Acid)IBA
01/2020 - 09/2007
3Genetic Markers (Genetic Marker)IBA
10/2017 - 03/2008
3Uroplakin IIIIBA
04/2017 - 04/2008
3Fluconazole (Zonal)FDA LinkGeneric
12/2016 - 01/2011
3Cyclin D3IBA
01/2016 - 09/2004
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2016 - 03/2014
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2015 - 04/2007
3Complementary DNA (cDNA)IBA
01/2015 - 09/2008
3Keratins (Keratin)IBA
08/2014 - 02/2007

Therapy/Procedure

130Therapeutics
12/2023 - 04/2003
71Prostatectomy (Retropubic Prostatectomy)
02/2023 - 01/2002
34Immunotherapy
10/2023 - 01/2016
25Drug Therapy (Chemotherapy)
01/2023 - 01/2008
24Castration
04/2023 - 03/2011
15Radiotherapy
10/2023 - 06/2002
12Cystectomy
04/2022 - 06/2003
12Precision Medicine
01/2020 - 03/2012
12Nephrectomy
01/2019 - 06/2008
8Lymph Node Excision (Lymph Node Dissection)
11/2019 - 05/2005
3Lasers (Laser)
01/2021 - 03/2008
3Adjuvant Chemotherapy
12/2014 - 07/2011